Epilepsy Digital Experience Navigator Developed for Improved Experience for Individuals with Epilepsy

The Epilepsy Digital Experience Navigator (EDEN) is a new platform being developed to enable individuals with epilepsy, caregivers, and clinicians to use data to improve daily life with epilepsy. The platform can provide a connection to care, resources, and information for individuals with epilepsy specified to their experience. The platform should be launched by Fall 2021.

"The Epilepsy Foundation is committed to shaping the future of epilepsy research and leveraging technology to create greater efficiency in epilepsy care and treatment," said Jacqueline French, MD, chief medical and innovation officer, Epilepsy Foundation. "Getting the right information to the right person at the right time is critical for successfully managing epilepsy. Our collaboration with Eisai empowers people with epilepsy to successfully manage their condition while contributing to research that we hope can help improve standards of care in the future for people living with epilepsy." 

The platform will accumulate and analyze medical records, survey responses, and additional data from other devices to provide education about new therapies and distribute new original tools and resources.

"At Eisai, everything we do is guided by our Human Healthcare (hhc) mission, putting patients and their families first while we also listen and learn from them. We seek to enable people to live their fullest lives and continue to pursue the creation of solutions based on scientific evidence to help them achieve this," said Ivan Cheung, chairman, Eisai Inc. and global president, Neurology Business Group, Eisai, "Partnering with the Epilepsy Foundation on the launch of EDEN continues our commitment to patients and families in the epilepsy community, as we together pursue and advance new epilepsy solutions."

The information obtained via the platform may help clinicians and researchers better interpret data to improve epilepsy outcomes.

"We are delighted to partner with the Epilepsy Foundation and Eisai to build EDEN," said Robert Chu, chief executive officer of Embleema. "For the first time, patients will be able to directly contribute to research by continuously sharing rich real-world insights with stakeholders in a fully remote and consented manner, while at the same time benefit from personalized digital services to better manage their condition."